Newspaper Publication of Audited Financial Results for the Quarter/ Year ended on 31st March, 2026. Thanks
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indo Us Bio-Tech Ltd has published its audited standalone financial results for Q4 and full year FY2026 ended March 31, 2026. Total income from operations grew by 6.2% to Rs 11,049.33 Lakhs compared to Rs 10,402.04 Lakhs in FY2025. However, profit before tax declined by 15.8% to Rs 1,392.02 Lakhs from Rs 1,653.06 Lakhs. Net profit fell by 19.3% to Rs 1,312.29 Lakhs from Rs 1,626.74 Lakhs. Tax expenses more than tripled to Rs 79.73 Lakhs from Rs 26.32 Lakhs. EPS dropped to Rs 6.54 from Rs 8.11 per share. For Q4 standalone, total income was Rs 3,350.41 Lakhs with net profit of Rs 368.48 Lakhs.
Revenue growth was offset by significantly higher tax expenses and reduced profitability. Shareholders may see negative sentiment as earnings per share declined nearly 20% year-on-year despite higher sales.